Palisade Bio Inc (PALI) concluded trading on Wednesday at a closing price of $1.22, with 11.87 million shares of worth about $14.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.21% during that period and on July 23, 2025 the price saw a gain of about 41.86%. Currently the company’s common shares owned by public are about 4.80M shares, out of which, 4.76M shares are available for trading.
Stock saw a price change of 62.45% in past 5 days and over the past one month there was a price change of 73.94%. Year-to-date (YTD), PALI shares are showing a performance of -71.82% which decreased to -26.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.60 but also hit the highest price of $4.65 during that period. The average intraday trading volume for Palisade Bio Inc shares is 337.67K. The stock is currently trading 57.15% above its 20-day simple moving average (SMA20), while that difference is up 65.96% for SMA50 and it goes to -15.74% lower than SMA200.
Palisade Bio Inc (NASDAQ: PALI) currently have 4.80M outstanding shares and institutions hold larger chunk of about 5.43% of that.
The stock has a current market capitalization of $5.84M and its 3Y-monthly beta is at 1.33. It has posted earnings per share of -$8.90 in the same period. It has Quick Ratio of 2.81 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PALI, volatility over the week remained 22.05% while standing at 9.28% over the month.
Stock’s fiscal year EPS is expected to rise by 85.62% while it is estimated to increase by 36.52% in next year. EPS is likely to shrink at an annualized rate of 55.06% for next 5-years, compared to annual growth of 77.35% made by the stock over the past 5-years.
